SNEX · StoneX Group Inc. · Stock research

Current Thesis

The June momentum thesis has been paid out and then some — in the wrong direction. SNEX closed at an all-time high of $139.01 on 2026-06-18 and traded $102.99 on 2026-07-17, a 26% round-trip in under a month with no fundamental news to explain it. The decline was orderly and relentless: -12.5% over the trailing week, -22.4% over the trailing month, with the stock cutting through the $118 shelf that had defined the early-June breakout over the prior $125.42 high. The 3-for-2 split that was supposed to be the momentum vehicle into the fiscal Q3 print instead distributed into a falling tape; split-adjusted trading opens 2026-07-20 with the stock near $68.66 equivalent. What sold was not the business — fiscal Q2 was genuinely excellent — but the multiple that a doubled stock trading 10%+ above every published target had accumulated. The 2026-08-04 fiscal Q3 print is now a rescue mission rather than an accelerant, and buying a 26% drawdown into a binary event three weeks after management sold the high is the setup this playbook exists to avoid.

Bullish and bearish views on StoneX Group Inc.

The model's bull view on StoneX Group Inc. (SNEX), in brief: Fiscal Q2 2026 (2026-05-06): record net operating revenue $829.1M (+70% YoY), net income $174.3M (+143%), diluted EPS $2.07 vs $0.94, ROE 26.5% — broad-based across Commercial, Institutional, Self-Directed and Payments. The bear view: The tape has broken. A 26% decline from the 2026-06-18 high with zero negative headlines is a valuation reset, and resets that start without news tend to end without news — there is no event to buy against. Insider distribution is the cleanest read available: $94.2M sold over… Both cases follow in full.

Bull Case

• Fiscal Q2 2026 (2026-05-06): record net operating revenue $829.1M (+70% YoY), net income $174.3M (+143%), diluted EPS $2.07 vs $0.94, ROE 26.5% — broad-based across Commercial, Institutional, Self-Directed and Payments.
• Fiscal Q1 2026 (Feb 2026): net income $139.0M (+69% YoY), total revenues $38.5B (+40%) — the Q2 record was the second consecutive quarter of triple-digit-adjacent profit growth, not a one-print artifact.
• FY2025 full year: revenue $130.90B (+32.6% YoY), earnings $295.5M (+17.4%). Trailing EPS $5.65 (+43.5%) puts the pre-split P/E at 18.2x — a market multiple for a business compounding at this rate.
• R.J.
• Two covering analysts carry Strong Buy with an average target of $123 pre-split (~$82 adjusted), roughly 19% above the 2026-07-17 close — the stock has fallen back below consensus for the first time since early June.
• Franchise expansion continues: WCS International UK wholesale banknotes (2026-03-31), the Pathfinder Group cross-border payments collaboration (2026-03-30), and a Financial Institutions Group research practice launched 2026-06-24.

Bear Case

• The tape has broken. A 26% decline from the 2026-06-18 high with zero negative headlines is a valuation reset, and resets that start without news tend to end without news — there is no event to buy against.
• Insider distribution is the cleanest read available: $94.2M sold over three months, no purchases.
• Sell-side is trimming exposure into the decline rather than defending it — a public Seeking Alpha downgrade to Hold ("quite the run") landed as the stock rolled over.
• The +70% Q2 revenue surge leans on the RJO addition plus an elevated-volatility regime. Vol compression mechanically slows derivatives, FX and physical-contract revenue, and FY2027 laps a fully-integrated RJO against much harder comps.
• Diluted EPS growth (+120% in Q2) trailed net income growth (+143%) on RJO-related share issuance; part of the growth was bought, and dilution caps the per-share translation.
• The 2026-08-04 print is binary into a tape that has already lost its trend structure. A merely in-line quarter does not repair a chart that gave back a month of gains in four weeks.

Setup & Price Structure

Split-adjusted, the reference points that matter are $92.67 (the 2026-06-18 all-time-high close), $94.66 (the $141.99 52-week high), $83.61 (the prior $125.42 high that was broken and has now been lost again), and $68.66 (the 2026-07-17 close). Price sits roughly 26% below the high and below both the 20-day and 50-day averages, with the May consolidation zone — roughly $70–83 adjusted — now overhead supply instead of support. The 52-week low at $35.68 adjusted is irrelevant to this timeframe; the live question is whether the rising 40-week average, which sits meaningfully below current price after an 82% market-cap gain over the year, gets tested. Volume on the 2026-07-17 decline (1.31M shares) ran well above the recent average, consistent with distribution rather than drift. The pattern here is a momentum name that ran to consensus, blew through it, saw management monetize, and mean-reverted — the archetype of a stretched-above-MA chase punished on schedule. A first bounce off a 26% drawdown into an earnings date is not a base. Nothing in this structure earns fresh capital; the stock needs weeks of sideways repair above the 40-week average before a breakout retest is even a conversation.

Catalyst Calendar (next 30 days)

No upcoming dated catalysts on file — the dated entries below have passed.

Elapsed catalysts

• 2026-07-20 — Split-adjusted trading begins (3-for-2). Mechanical, already discounted; the split arrived into weakness rather than driving strength. Watch for the post-split retail bid that historically follows — its absence would confirm the narrative has no marginal buyer. (passed 20d ago)
• 2026-07-30 — Earnings blackout begins (3 trading days ahead of the print). No fresh entries past this date. (passed 10d ago)
• 2026-08-04 — Fiscal Q3 2026 results. Consensus EPS ~$1.21 split-adjusted. The bar that actually matters is net operating revenue against the $829.1M Q2 base and listed-derivatives volume against the ~100M-contract Q2 pace. Screener "revenue" consensus near $264M is not comparable to the company's reported net-operating-revenue line and should not be used as a beat/miss threshold. (passed 5d ago)
• ~2026-08-05 to 2026-08-08 (est.) — Post-print analyst revisions. With price back below the $123 pre-split average target, a target-cut cluster here would confirm the sell-side is chasing the tape down; a target raise into a good print is the first genuine re-acceleration signal. (passed 1d ago)

What Would Change Our Mind

The bearish structural read gets overturned by a clean sequence, not a single green day: fiscal Q3 on 2026-08-04 printing net operating revenue growth still above 30% YoY with derivatives volume holding the ~100M-contract pace, followed by four-plus weeks of sideways consolidation that holds above the 40-week average and above the $64 adjusted line, then a breakout retest on expanding volume. Insider behaviour is the second key: any cluster of open-market purchases after a $94.2M three-month distribution wave would be a material change in what management thinks the stock is worth. A volatility-regime shock — a commodities or rates dislocation that drives FCM clearing volumes materially higher — would also re-fire the earnings power narrative independent of the chart. Absent those, lower prices are information, not opportunity.

Correlation Notes

SNEX trades as a derivatives-clearing and market-volatility beneficiary, so it correlates less with the financials complex broadly than with realized volatility in commodities, FX and rates. The direct comparison set is the listed-venue and clearing cohort — CME, ICE, Virtu, Marex — where revenue is a function of contract volume rather than credit or net interest margin. That means the name inversely tracks vol compression: a grinding, low-VIX melt-up in equities is a headwind to the exact revenue line that produced the Q2 record. Secondary exposure runs through cross-border payments (WCS International, Pathfinder) and the Self-Directed retail brokerage segment, which is levered to retail engagement and therefore to the same speculative appetite that just exited the stock itself. The prior crypto-exchange theme association is retired — digital assets is a negligible sliver of the revenue mix and has never driven the tape here. Against the FCM peer group, the 2025-07-31 RJO acquisition makes SNEX the volume-share consolidator, which cuts both ways: it captured the scale, and it also carries the integration and comp-lapping risk that peers do not.